When a company publicly reaffirms its commitment to profitability, it often leads to increased investor confidence. This confidence can translate into a higher demand for the company's stock, potentially driving up its price. Given that ReShape Lifesciences has made such a commitment, it is reasonable to expect a positive reaction from the market, at least in the short term. However, the actual impact will depend on the company's ability to meet these profitability goals and the broader market conditions.